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1. Introduction
This paper uses two analytical methods − event study analysis and cross-sectional
analysis − to empirically analyze the impact of revisions in accounting standards for research
and development (R&D) expenditure on short-term stock returns in the Japanese manufacturing
industry.
Prior to 1999, R&D expenses were classified as either experimental and research costs or
as development costs and, in either case, could be recognized as deferred assets. In 1998,
however, new accounting standard was announced regarding R&D expenditures titled
“Accounting standard for Research and Development costs.” According to the new standard,
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R&D expenditures were henceforth to be treated as being incurred at the time they arise.
Sakurai (1999) points out that, from the viewpoint of industrial policy, this accounting
treatment inhibits R&D investment by Japanese companies. Otogawa and Otomasa (2004)
view such standard as inappropriate with respect to the stock market.
Further, the standard required that in-process R&D (IPR&D) acquired through corporate
mergers be treated in the same manner as internal R&D expenditures by being expensed at
the time incurred. However, in 2008, the regulatory authority − the Accounting Standards
Board of Japan (ASBJ) − published Statement No. 23, “Partial Amendments to Accounting
Standard for Research and Development Costs” to better conform to international
standards1. After this revision, the scope of application of the previous R&D accounting
standards no longer included assets obtained as the result of a merger. In other words, IPR&
D was no longer recorded as an incurred expense, but could instead be capitalized as an
asset.
However, there has been no research on the short-term effects of the ASBJ Statement No.
23 on stocks in Japan. Clem, Cowan and Jeffrey (2004) indicate that stock market reactions
are used to infer the capital market’s assessment of the expected impact of any changes in
regulation and to evaluate whether regulatory actions result in inappropriate application of
Generally Accepted Accounting Principles (GAAP) on the one hand, or potentially less
informative disclosure about IPR&D on the other.
In this study, I use the event study analysis to examine the relationship between revisions
in Japanese accounting standards on R&D costs and short-term stock returns, and to
determine whether there are any differences between the Japanese and US markets in this
context. My study also investigates whether there is a relationship between corporate
characteristics and abnormal stock returns as a result of the publication of revised
accounting standards. In other words, the question under consideration is: How are corporate
characteristics reflected in short-term stock returns?
2. Previous Research on R&D
Current accounting standards both in Japan and the United States require that internal R
&D costs be treated as expenses at the time they are incurred. However, Yaekura (2006) has
indicated that no study has found improved utility of accounting information from such
treatment of R&D costs. Expensing means that quarterly and annual R&D expenses are
subtracted from revenues (sales) in the process of calculating net income (earnings). Deng
and Lev (2006) hold that the major characteristic of an expense that distinguishes it from an
asset (capital) is that it is not expected to generate future benefits. They also consistently
1 For details, see the FASB (2001b, 2007) and IASB (2012).
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argue that this asset-expense distinction clarifies the major controversy concerning R&D
expensing: there is no doubt that R&D activities are expected to generate future benefits,
such as from sales of drugs or software products.
A number of studies have been conducted on R&D cost accounting from the perspective
of the value relevance2 of accounting information. Indeed, extensive empirical evidence
documents a significant statistical association between current and past R&D expenditures
by companies, and future growth in sales, earnings, and stock prices3. Representative early
examples of such research in the United States include Sougiannis (1994) and Lev and
Sougiannis (1996).
Sougiannis (1994) examines whether reported accounting earnings reflect benefits from
past R&D expenditures, and uses the benefits, if any, to estimate the investment value of R
&D. The results from the earning model he uses indicate that reported earnings, adjusted for
the expensing of R&D, do reflect realized benefits from R&D. On average, a one-dollar
increase in R&D expenditures leads to a two-dollar increase in profit over a seven-year
period. The results from the valuation model indicate that investors place a high value on R
&D investments. On average, a one-dollar increase in R&D expenditure produces a five-
dollar increase in market value.
Lev and Sougiannis (1996) attempt to establish an empirical connection between R&D
expenditure and subsequent earnings. First, they estimate the relationship between R&D
expenditure and subsequent earnings for a large cross-section of R&D-intensive firms. Then
they adjust earnings and book values of the sample firms for R&D capitalization and show
that the adjusted values are significantly associated with stock process and returns,
indicating the value-relevance of the R&D capitalization process to investors. Finally, they
demonstrate, in an inter-temporal context, that R&D capital is reliably associated with
subsequent stock returns. They therefore argue that the association between R&D
expenditure and subsequent earnings is both statistically significant and economically
meaningful.
Itsikawa and Nakano (2005) and Sakakibara et al. (2006) are representative of the
relevant studies in Japan. Ichikawa and Nakano (2005) use a sample of 49 chemical firms
listed on the First Section of the Tokyo Stock Exchange (TSE-1)4 from 1980 through 2001.
Their research shows a positive relationship between R&D expenditure and corporate value.
2 Barth, Beaver and Landsman (2001) argue that an accounting amount is defined as value-relevant if it
has a predicted association with equity market values. The value-relevance literature provides useful
insights for standard setting.
3 Lev (2001) and Hand and Lev (2003) are excellent summaries of the results of research in the United
States. Tan (2011) and Nakano (2013) summarize research in Japan.
4 The Second Section of the Tokyo Stock Exchange is denoted as TSE-2.
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Sakakibara et al. (2006) take into consideration 4,173 Japanese manufacturing firms listed
on TSE-1 and TSE-2 from 1991 through 2004, and show a direct relation between R&D
expenditure and stock prices in various industries.
Thus, there has been considerable emphasis in both US and Japanese studies on the
argument that R&D expenditure should be treated as an intangible asset rather than merely
as expenditure for the fiscal year, since such expenditure is a driver of corporate growth, as
well as a source of expected future cash flows. Linsmeier et al. (1998) have indicated that
capital markets ascribe asset-like status to R&D expenditures.
Otogawa and Otomasa (2004) use the event study analysis to investigate the stock market
response to the December 1997 publication of the exposure draft on R&D accounting
standards. They examine data on 247 R&D-type firms5 that were continuously listed on the
TSE from January 1997 to December 2000. Their research indicates a significant drop in
corporate stock prices from the day before to the day after publication of the exposure draft.
They attributed this to revised market expectations in light of the proposed new standard,
reflecting popular opinion that the changes would have a negative effect on R&D activities.
Recent studies, particularly those in the US, have increasingly indicated problems in the
treatment of IPR&D in the same way as company-internal R&D costs6. At one time, the R&
D standards in the United States were similar to those in Japan. During 2004, the FASB
(Financial Accounting Standards Board), the US regulatory body, issued an exposure draft
that discussed the proposal to capitalize IPR&D and subject it to a periodic impairment test.
A final exposure draft was published in 20057.
Deng and Lev (2006) examine whether IPR&D is an asset worthy of capitalization or an
expense, and if it is an asset, how reliably it is estimated estimate. They find a significant
association between the values of IPR&D and the cash flows of acquiring firms during the 3
years subsequent to acquisition, thus supporting the FASB’s proposal to recognize IPR&D
as an asset. Therefore, they predict that allowing capitalization of IPR&D will have a
fundamentally positive effect on the market.
Clem, Cowan and Jeffrey (2004) use the event study analysis to document market
reactions to a series of regulatory events related to IPR&D during 1998-1999. They note
that, on average, stock prices of the sample firms reacted negatively to announcements of
SEC (U.S. Securities and Exchange Commission) scrutiny of IPR&D charges. They also
5 In Otogawa and Otomasa (2004), an “R&D-type company” is defined as a company in which
consolidated basis R&D expenditures accounted for by the close of fiscal 2000 exceeded 3% of the
firm’s start-of-year assets.
6 For details, see the FASB (2001a).
7 For details, see the FASB (2005). In 2007, new accounting standard was announced regarding business
combination titled “Statement of Financial Accounting Standards No. 141 (revised 2007) Business
Combinations.” This Statement replaces FASB Statement No. 141.
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found a positive price reaction to the FASB’s decision in the late 1990s to defer statutory
capitalization of IPR&D. The authors interpreted these findings as evidence that investors
‘‘the market is more concerned about increased regulation of IPR&D than about the
reliability of accounting estimates.’’ They use cross-sectional analysis to examine four firm-
specific variables: firm size, R&D expenses, recent acquisitions, and industry membership.
The results indicate that the predicted reactions are strongest for firms with historically high
R&D expenses, especially those in the software industry. Larger firms, particularly those
with experience in acquiring firms with current R&D expense, are less negatively affected
by a call for the financial community to participate in reducing IPR&D charges. Finally, the
results also show that firms having the greatest exposure to regulators’ concerns have the
most negative valuation impact.
There has, however, been no previous research conducted that uses event study analysis
to explore the short-term stock market effects of the publication of ASBJ Statement No. 23.
This paper investigates the relation between short-term stock returns and revisions to R&D
accounting standards, particularly the R&D accounting standards resulting from the 1997
and 2008 revisions to rules on R&D expenditures. I am particularly interested in examining
whether there are any deviations from the findings of the latest research in the United
States. This verification is performed through the use of associated events and investigation
of the stock market response8.
3. Research Design
3.1 Sample Selection
The data set of Event 1 covers the period from January 1997 to January 1999, while
Events 2, 3, and 4 cover the period from January 2007 to January 2009. I examine the
market reaction to four events during the two periods. Table 1 summarizes the events.
All the firms selected were continuously listed on the TSE-1 or TSE-2 from January
1997 to December 2009. Daily stock price data was taken from The Stock Prices 2010 CD-
ROM by Toyo Keizai Inc.
8 Clem, Cowan and Jeffrey (2004) use articles from The Wall Street Journal as the basis for their event
study analysis. Miyamoto (2005) points out that the closest Japanese equivalent of The Wall Street
Journal is the Nihon Keizai Shimbun. My paper follows the method of Clem, Cowan and Jeffrey
(2004) and Miyamoto (2005), analyzing responses to relevant articles in four newspapers published by
Nikkei Inc. These are the Nihon Keizai Shimbun, the Nikkei Marketing Journal, the Nikkei Business
Daily, and the Nikkei Veritas. I found one article in Nihon Keizai Shimbun. Publication of the article
has been referred to as “Event 2” in this paper. Following Otogawa and Otomasa (2004), the
publication of the exposure draft “Accounting standard for Research and Development costs”
(December 22, 1997) will be referred to as “Event 1”, the publication of the exposure draft of ASBJ
Statement No. 28 (June 30, 2008) as “Event 3”, and the publication of ASBJ Statement No. 23
(December 22, 2008) as “Event 4”.
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Figure 1. Time line for an event study
3.2 Method of Measuring Short-term Abnormal Returns Related to the Publishing of
Accounting Standards Revisions
3.2.1 Calculating Returns
Denote by Pt the price of an asset on date t and assume for now that this asset pays no
dividends. The simple net return, Rt, on the asset between dates t1 and t is defined as
Rt PtPt11 (1)
3.2.2 Measuring Abnormal Returns
Broadly speaking, in event study analysis one estimates a market model for some time
preceding an event (the estimation period) and then uses that model to calculate the
abnormal return for a period before and after the event (the event period). This allows
examination of the event’s influence on the market. This paper takes the day of the event as
T0, and sets the estimation period (190 days) and the event period (21 days) as described
below.
The abnormal return is defined by equation (2):
ARi, tRi, tERi, tXt. (2)
Table 1. Event Date and Descriptions
Event Number Event Date Event Type
Event 1 22, December, 1997 The publication of the exposure draft “Accounting Standard for
Research and Development Costs”.
Event 2 13, December, 2007 Newspaper article (The Nihon Keizai Shimbun) “Partial
Capitalization of R&D Costs”.
Event 3 30, June, 2008 The publication of the exposure draft of ASBJ Statement No.
28, “Amendments to A part of Accounting Standard for
Research and Development Costs”.
Event 4 22, December, 2008 The publication of ASBJ Statement No. 23, “Partial amendments
to Accounting Standard for Research and Development Costs”
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Here, Ri, t is the return calculated from equation (1), and Xt is the condition for finding
the normal return on day t. This paper uses the Fama-French three-factor model to estimate
the normal return under conditions X (Fama and French 1992)9.
Ri, tRf, tαiβ1Rm, tRf, tβ2SMBtβ3HMLtεi, t (3)
Here,
Ri, t is the stock return for company i on day t,
Rf, t is the risk-free rate (10-year government bond yield) on day t,
Rm, t is the market portfolio return (TOPIX) for day t,
SMBt is the difference between returns for large-cap and small-cap portfolios on day t,
HMLt is the difference between returns for a growth stock portfolio and a value stock
portfolio on day t, and
εi, t is an error term for day t.
αˆ, β1, β2, and β3 are parameters estimated for equation (3) by the least squares method,
and these parameters are used to estimate abnormal return over the event period (10 t
10).
ARi, tRi, tαˆβ1Rm, tRf, tβ2SMBtβ3HMLtεi, t (4)
ARi, t in equation (4) is a measure of deviation from the normal return pattern for each
stock. If there is a market response to an announcement of new accounting standards, that
response should be reflected in ARi, t. In other words, the event of the accounting standards
revision is an exogenous factor for changes in stock prices. Alternatively, changes in stock
prices are triggered by an accounting standards revision event.
3.2.3 Aggregation of Abnormal Returns
To consider what kind of average effect events of accounting standards revision might
have on stock prices, I take the average of the abnormal rate of return ARi, t at time t of
sample firm i from among N total sample firms. Then, the average abnormal return at time
t, AARt, is given by equation (5).
AARt1NΣNi1ARi, t (5)
9 The market model is a single-factor model that considers market factors only, so variance in the
abnormal return is often viewed as a problem. This is particularly the case in situations such as the one
considered in this paper, in which the sampled organizations all belong to the same industry, so that
they are highly likely to have similar characteristics. In such cases, it is worth considering use of a
multi-factor model. This can greatly reduce the variance in abnormal returns. See Campbell, Lo and
MacKinLay (1997) for a theoretical commentary on single- and multi-factor models.
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In the event study analysis, I use the cumulative abnormal return conventionally, with the
goal of observing accumulated information and observing whether the event’s effect extends
over any period. That is, comprehensive reasoning about events requires aggregation of
observed average abnormal returns. CAAR (τ1, τ2) is the average abnormal return over
period τ . It is defined as the cumulative average abnormal return from τ1 to τ2, as follows:
CAARτΣ ττ2ττ1AARτ (6)
3.2.4 Statistical tests
This paper investigates whether the event of accounting standards revision has an effect
on stock prices. In other words, we test the null hypothesis that the event of accounting
standards revisions related to R&D expenditure has no effect on stock prices, and the
average abnormal return is zero. Then, using the fact that AARt and CAARτ follow normal
distributions, we perform parametric hypothesis testing. Because the event might result in
non-uniform variation, we use the standardized cross-sectional test proposed in Boehmer,
Musumeci and Poulsen (1991). To confirm the robustness of the estimation results, we also
perform a non-parametric test of the sign that makes no assumptions about the distribution
of the abnormal return, according to Cowan (1992). According to Goto (1997), in addition
to parametric and non-parametric testing it is also reasonable to perform a t-test in which
the standard deviation is calculated from a time series of average abnormal returns over the
market model estimation period. In this paper, therefore, hypotheses verification and
robustness testing employs these three methods.
4. Empirical Results (1): Short-Term Abnormal Return
Table 2 shows the CAAR for the four manufacturing industry events over three periods:
from 10 days before to 10 days after the event (-10, +10), from 3 days before to 3 days
after the event (-3, +3), and from 1 day before to 1 day after the event (-1, +1).
Examining Event 1, CAAR (-10, +10) is approximately -1.1% and statistically significant
at the 5% level. CAAR (-5, +5) trends negative, but is not statistically significant. CAAR
(-1, +1) is approximately -1.2% and statistically significant at the 1% level. CAAR was not
statistically significant for any of the three periods under non-parametric tests.
Event 1 is the standards revision event of 1997, in which the R&D accounting standards
exposure draft was published, amending the previous rule on deferring capitalization of R&
D costs and requiring, instead, immediate expensing of those costs. The verifications
performed above indicate a significant negative effect on company stock prices as a result of
the announcement of the R&D accounting standards revisions.
Events 2-4 are related to the 2008 publication of the partial revision of the R&D
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Table 2. Stock-Price Reactions of Firms in R&D-Manufacturing Industries to Events
Relating to Accounting Standards Revisions for R&D in the Period January
1997-January 2009.
Event Date Window CAAR t-test 1 t-test 2 t-test 3
Event 1 19971222 CAAR (-10, +10) -0.011 -2.166 -1.971 1.363
CAAR (-5, +5) -0.003 -0.906 -0.518 -0.240
CAAR (-1, +1) -0.012 -6.160 -3.122 -0.429
Event 2 20071213 CAAR (-10, +10) 0.014 4.500 5.958 6.336
CAAR (-5, +5) 0.009 3.975 5.324 6.197
CAAR (-1, +1) 0.006 4.909 6.839 7.028
Event 3 20080630 CAAR (-10, +10) -0.021 -5.718 -5.738 -5.851
CAAR (-5, +5) -0.012 -4.513 -4.403 -4.282
CAAR (-1, +1) -0.001 -0.727 -0.288 -1.586
Event 4 20081222 CAAR (-10, +10) 0.123 0.352 3.464 15.563
CAAR (-5, +5) 0.818 3.228 4.683 19.503
CAAR (-1, 1) 0.435 3.288 3.427 8.716
CAAR is Cumulative Abnormal Return. t-test 1 is t test time series (Patell 1976), t-test 2 is cross
sectional test (Boehmer, Musumeci and Poulson 1991), and t-test 3 is a non-parametric sign test
(Cowan 1992).
accounting standards, which stated that under certain conditions IPR&D could be
capitalized. Taking specific results from Table 1, CAAR (-10, +10) shows a positive result,
significant at the 1% level for Events 2 and 3 when Event 4 is excluded, and CAAR (-5,
+5) and CAAR (-1, +1) each show a statistically significant positive result at the 1% level
for Events 2 and 4 when Event 3 is excluded. These test statistics are also significant at the
1% level under non-parametric tests.
5. Effects of Firm Characteristics on Stock Price Reaction: Cross-sectional Test10
5.1 Research Design
This section addresses the second topic for analysis, a consideration of how corporate
characteristics affect short-term abnormal stock returns. We will focus, in particular, on
features such as corporate growth and scale of R&D, and posit the following hypotheses:
Hypothesis 1: Corporate growth has a positive effect on short-term abnormal stock
10 Kothari and Warier (2007) show that cross-sectional tests examine how the stock price effects of an
event are related to firm characteristics. For a cross-section of firms, abnormal returns are compared to
firm characteristics. This provides evidence to discriminate among various economic hypotheses.
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returns.
Hypothesis 2: R&D scale has a positive effect on short-term abnormal stock returns.
To validate these hypotheses, we perform regression analysis of the CAAR value
obtained in Section 4 as the dependent variable. In the regression, corporate growth and R&
D expenditure are explanatory variables; the control variables are market beta, profitability,
and leverage.
CAARi, tα0α1Betai, tα2BPi, tα3R&Di, tα4ROAi, tα5Leveragei, tμi, t (7)
Here,
CAARi, t is the 11-day CAARi, t (-5, +5) value for firm i from 5 days before to 5 days
after the event;
Betai, t is the market beta, estimated by the capital asset pricing model (CAPM), for firm
i from 11 business days before the event;
BPi, t is the ratio of equity at book value versus market value for firm i as of 11 business
days before the event;
R&Di, t is the natural logarithm of R&D expenditure for firm i over period t;
ROAi, t is the ratio of operating income to total assets for firm i over period t; and
Leveragei, t is the ratio of shareholder equity to total capital for firm i over period t.
Market beta, corporate growth, and company size are the three factors in the Fama-
French three-factor model, and are corporate features well known to have a strong influence
on stock performance. I therefore use the stock’s beta, as estimated by the CAPM, as a
proxy for risk factors.
Often viewed as a proxy for company growth opportunities, the book-to-price ratio (B/P)
is also used as an index for assessing over- or under-evaluation of stock prices.
This paper uses the scale of R&D expenditure as an explanatory variable. The concept of
scale effects in R&D investment has a long history, going back to Schumpeter (1942).
Gaver and Gaver (1993) argue that large companies usually have a better ability to develop
new investment opportunities than small companies. Recent studies such as Ciftci and
Cready (2011) empirically show that in large Western companies, increased company size
results in increased future profits from R&D investment, and Nimi (2012) shows similar
results for publicly traded Japanese firms. R&D activity requires economies of scale;
therefore, this paper incorporates R&D scale as an explanatory variable in the analysis.
Further, because company size and the scale of R&D investment are highly correlated,
multicollinearity may arise when both variables are incorporated into the same model;
therefore, equation (7) only incorporates an R&D scale variable.
Return on assets (ROA), which is an excellent indicator of a firm’s performance, is used
as the explanatory variable measuring a firm’s profitability. As for total assets (the
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denominator for ROA), the value of total assets from the balance sheet is used. As to profits
(the numerator), various types of profits can be used. Here, we use business profits, laying
emphasis not only on judging the profitability of assets with a focus on the operation of the
main business, but also on the contribution of the creation of corporate value to assets in
place. Since business profits are generated from assets in place, the inclusion of business
profits among the explanatory variables is considered a reliable index of the contribution to
corporate value of the assets in place.
I have also added a control variable for financial leverage. Arikawa, Kwanishi, and
Miyajima (2011) show that although large companies in Japan partially fund R&D efforts
through debt, increased liabilities by small businesses monotonically reduce R&D
expenditure. According to Penman (2012), there is a tendency towards increased corporate
value in companies with high financial leverage. Here, the ratio of total capital to
shareholder equity is used as a proxy for financial leverage.
5.2 Sample Selection
The above empirical model (7) is estimated with data covering the period 1997-2008.
The data is particularly useful in that it is representative of firms from a broad spectrum of
the Japanese manufacturing industry. The data set satisfies all four criteria. The firms
included (1) are manufacturing firms listed on TSE-1 and TSE-2, and (2) settle their
accounts in March. Firms with different account settlement periods announce their financial
statements at significantly different times. Inclusion of firms with different account
settlement periods in the sample would lead to different levels of stock prices used in the
analysis. To avoid such inconsistency, the firms considered here are limited only to those
settling their accounts in March. Since most Japanese firms settle in March, a relatively
large sample is obtained for this account settlement period. Also, (3) there is no change in
the timing of account settlement between the current period and the following period. This
criterion is necessary for comparison of the variables among firms in equation (7). Finally,
(4) R&D expenditure is reported in the financial report.
Data from the top 0.5 percent and lower 0.5 percent of the variables are deleted as
outlier.
Stock price data has been taken from the Stock Prices 2010 CD-ROM by Toyo Keizai
Inc., and financial data from NEEDS, the Nikkei Financial Data 2010 CD-ROM by Nikkei
Inc.
5.3 Descriptive Statistics and Correlation Coefficients
Descriptive statistics for the variables used in this paper are shown in Table 3. The
distributions of variables have little bias as the mean and median of each variable are
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Table 3. Descriptive Statistics for the Variables
Event Variable Average Standard
Deviation
Maximum Median Minimum Event Average Standard
Deviation
Maximum Median Minimum
Event 1 CAAR -0.010 0.100 0.243 0.100 -0.316 Event 2 0.011 0.063 0.351 0.011 -0.248
Beta 1.886 2.484 10.903 2.484 -3.258 0.783 0.785 6.004 0.728 -1.496
B/P 0.906 0.464 3.019 0.464 0.026 1.010 0.575 4.746 0.904 0.118
R&D 8.480 1.678 13.144 1.678 2.708 7.487 1.817 13.049 7.386 0.000
ROA 0.038 0.034 0.186 0.034 -0.028 0.068 0.050 0.436 0.062 -0.194
Lev. 3.261 2.119 16.872 2.618 1.088 2.287 1.213 16.758 1.987 1.081
Event 3 CAAR -0.012 0.067 0.503 -0.015 -0.263 Event 4 0.940 9.015 61.779 -0.587 -37.508
Beta 0.595 0.998 6.831 0.529 -10.078 0.770 1.824 14.193 0.578 -13.932
B/P 1.084 0.569 4.637 0.985 0.028 1.873 1.205 13.002 1.626 0.132
R&D 7.534 1.857 13.034 7.448 0.000 7.568 1.836 13.034 7.470 0.000
ROA 0.063 0.057 0.468 0.060 -0.294 0.065 0.055 0.468 0.061 -0.239
Lev. 2.395 4.637 126.333 1.945 1.066 2.241 1.325 25.388 1.945 1.066
relatively close to each other for every sample.
Table 4 shows the correlation coefficients among explanatory variables. To inspect
multicollinearity among the independent variables, the variance inflation factor is used. The
variance inflation factors are found to be below 2.3. Therefore, the problem of
multicollinearity, which potentially exists among the independent variables, does not seem to
be so serious, at least for the sample used here11.
5.4 Empirical Results (2): Cross-sectional Analysis
In respect of CAAR (-5, +5) for Event 1, market beta, corporate growth, and financial
leverage were each significant at no worse than the 5% level, but neither R&D expenditure
nor profitability was significant.
In respect of CAAR (-5, +5) for Event 2, corporate growth, R&D expenditure, and
financial leverage were each positively significant factors at no worse than the 5% level.
Regarding CAAR (-5, +5) for Event 3, corporate growth and R&D expenditure were
positively significant factors at the 1% level, and financial leverage was significant at the
5% level. In respect of CAAR (-5, +5) for Event 4, corporate growth and R&D expenditure
were positively significant factors at no worse than the 5% level, but neither corporate
profitability nor financial leverage was significant.
11 The variance inflation factor > 10 indicates the possibility of multicollinearity. For details, see Kennedy
(2003).
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Table 4. Correlation Coefficients for the Explanatory Variables
Event 1 Beta B/P R&D ROA Leverage Event 2 Beta B/P R&D ROA Leverage
Beta 1.000 Beta 1.000
B/P 0.047 1.000 B/P -0.095 1.000
R&D -0.001 -0.340 1.000 R&D 0.095 -0.302 1.000
ROA -0.109 -0.568 0.145 1.000 ROA 0.033 -0.427 0.166 1.000
Leverage -0.060 -0.148 -0.023 -0.085 1.000 Leverage 0.092 -0.166 -0.050 -0.250 1.000
Event 3 Beta B/P R&D ROA Leverage Event 4 Beta B/P R&D ROA Leverage
Beta 1.000 Beta 1.000
B/P -0.190 1.000 B/P -0.083 1.000
R&D 0.134 -0.288 1.000 R&D 0.038 -0.160 1.000
ROA 0.099 -0.462 0.221 1.000 ROA 0.103 -0.304 0.190 1.000
Leverage -0.024 -0.122 -0.023 -0.144 1.000 Leverage -0.021 -0.053 -0.045 -0.272 1.000
Table 5. Test of Effects of Firm Characteristics on Stock Price Reaction to Four Events
Relating to Rules for Accounting for R&D
CAARi, tα0α1Betai, tα2BPi, tα3R&Di, tα4ROAi, tα5Leveragei, tμi, t
CAAR Event 1 Event 2 Event 3 Event 4
Beta -0.008**
(-2.570)
0.001
(0.180)
-0.003
(-0.700)
0.173
(0.820)
B/P 0.054***
(2.940)
0.026***
(3.910)
0.015***
(3.170)
0.470**
(2.210)
R&D 0.004
(0.910)
0.005***
(3.290)
0.003***
(2.680)
0.834***
(4.200)
ROA 0.001
(0.010)
0.219***
(3.420)
-0.055
(-0.760)
10.888
(1.500)
Leverage 0.000***
(3.870)
0.004**
(2.230)
-0.001*
(-1.710)
0.046
(0.320)
Constant -0.083
(-1.460)
-0.075***
(-3.960)
-0.045***
(-3.170)
-7.189***
(-4.390)
Adj. R2 0.066 0.042 0.025 0.030
The t statistics based on White (1980) appear in parentheses. The symbols*, **, and *** respectively
denote statistical significance at the 0.1, 0.05, and 0.01 levels.
6. Explanation of empirical results
Table 2 shows the results of calculating CAAR according to the Fama-French three-
factor model. Table 5 shows the results of correlation analysis between the CAAR of each
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event and corporate characteristics. I end with an overview of these results and offer an
economic interpretation.
The results of analyzing the manufacturing firms listed in Table 2 show that Event 1 had
a statistically significant negative correlation with short-term abnormal returns, and that
there were statistically significant positive correlations between short-term abnormal returns
and Events 2, and 4. The results for Event 1 suggest that the publication of revisions to the
R&D accounting standard in 1997 had a significant downward effect on the next-day stock
prices of firms in the manufacturing industry. In contrast, the results suggest that publication
of partial revisions to R&D accounting standards in 2008, and a related article regarding the
possibility of partial capitalization of R&D expenditure, had a significant upward effect on
the next-day stock prices of firms in the manufacturing industry. Alternatively, I have found
that the publication of revisions to the R&D accounting standards in 1997 had a negative
effect on stock prices, but publication of partial revisions to R&D accounting standards in
2008 had a positive effect on stock prices.
Taking specific examples of CAAR movement from one day before to one day after the
event, the CAAR (-1, +1) from the day before to the day after was -1.2% and statistically
significant at the 1% level. In other words, Event 1 had an average effect of a 1.2% fall in
stock prices. These findings are in line with the results of Otogawa and Otomasa (2004).
In contrast to Event 1, when looking at the movement of short-term stock prices on the
day of Event 4 (the publication of partial revisions to R&D accounting standards on
December 22, 2008), we can verify a total average stock price response (i.e., CAAR (-1,
+1)) of 43.5% between the day before and the day after the event. In other words, this
accounting standard revision increased stock prices by 43.5% on average.
Considering the overall empirical results for all events, we notice that the 1997
publication of R&D accounting standards had a negative effect on stock prices, but the
publication of revisions to the R&D accounting standards in 2008 was viewed positively by
the stock market. The results of this study further indicate that Japanese investors do not
consider it appropriate to expense R&D costs as they occur, and instead prefer such costs to
be considered as assets.
Otogawa and Otomasa (2004) interpret the negative abnormal return from the publication
of the R&D accounting standard as market opinion that the new R&D accounting standards
requirements will have an adverse effect on R&D activities. One background factor in this
regard is the recent trend for shorter-term R&D activities in Japanese companies12.
12 For further information regarding trends in short-term R&D in Japanese firms, see the proceedings of
the 31st meeting of the METI (Ministry of Economy, Trade and Industry) Industrial Structure Council,
Industrial Technology Research and Development Division, Subcommittee on Research and Development.
http://www.meti.go.jp/committee/summary/0001620/031_haifu.html, accessed August 30, 2013.
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Immediate expensing of R&D costs may also result in a trend whereby companies have a
long-term R&D orientation when the economy is doing well and a short-term R&D
orientation when the economy is doing poorly.
The results of analysis in this study are in contrast to the findings of recent studies in the
United States. This study finds that Japanese capital markets positively evaluate the
publication of accounting standards for IPR&D expenditures. This can be interpreted to
mean that Japanese investors tend to focus on the status of value creation in Japanese firms.
Through cross-section analysis of correlations between the CAAR (-5, 5) for each event
(Table 5) and company characteristics, I found that corporate growth and R&D expenditure
had a statistically significant positive correlation, indicating that these variables have a
positive effect on short-term abnormal returns. Studies such as Sakakibara et al. (2006) and
Tan (2011) have pointed out that R&D activities in the manufacturing industry play an
important role in company growth. However, Sougiannis and Yaekura (2001) note that
immediate accounting of R&D expenditure is one of the causes of the increase in erroneous
evaluation of accounting information in those firms for which R&D expenditure is very
important. There is, therefore, a possibility that increased corporate growth and R&D
expenditure may lead to larger CAAR resulting from events such as revisions to R&D
accounting standards.
7. Conclusion
In this study, I first used event study analysis to statistically verify the extent to which
the publication of revisions to R&D expenditure-related accounting standards has an effect
on abnormal returns over the periods immediately before and after the event. This analysis
enabled investigation of whether the publication of new accounting standards has a short-
term effect on stock prices. This paper considers how company characteristics affect short-
term abnormal returns.
Through event study-based verification and comparison with the existing research, I
found that the 1997 revision to R&D accounting standards had the effect of lowering stock
prices. In contrast, the 2008 publication of partial revisions to the R&D accounting
standards, and a related newspaper article reporting the possibility of partial capitalization of
R&D expenditures, gave a significant boost to share prices of manufacturing firms.
These results lead us to the conclusion that the publication of revisions to the R&D
accounting standard titled “Accounting standard for Research and Development costs” had a
negative effect on stock prices, and publication of R&D accounting standard titled “Partial
amendments to Accounting Standard for Research and Development Costs”, had a positive
effect on stock prices.
The results of analysis of the correlation between company characteristics and short-term
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abnormal returns verified that corporate growth and R&D expenditures have a positive effect
on short-term abnormal returns. In other words, higher corporate growth and increased R&D
spending result in higher short-term abnormal returns.
Finally, in the extant literature on the value relevance of R&D expenditures, R&D has
been recognized as a value creation factor, and the asset-like features of R&D have been
demonstrated. The empirical results of this paper are consistent with the results of such
value-related research and show that Japanese investors support the capitalization of R&D
expenditures. If one of the goals of an efficient accounting system is to allow investors to
make more informed decisions, the results obtained here have many implications for future
accounting standards pertaining to R&D expenditures.
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